Liquidia Fends Off Indication Challenge In UTC Tyvaso Fight
By Theresa Schliep · May 5, 2025, 9:59 PM EDT
A D.C. federal court has rejected United Therapeutics Corp.'s challenge to a U.S. Food and Drug Administration decision allowing Liquidia Technologies Inc. to modify a new drug application to include an...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login